CAS: 22037-28-1; 3-Bromofuran

该化合物是一种含有分子式C4H3BRO的溴化杂环化合物,在3个位置上用溴原子取代了一只呋喃环,该化合物主要用作有机合成的多用途中间体,特别是用于制备药品,农用化学品和特殊化学品.其反应性溴共性能够产生高效的交叉反应,如铃木或Stille组合,为建造复杂的分子结构提供便利. 呋喃环有助于其循环和功能化反应的实用性. 3-Bromofuran因其在标准条件下的稳定性和与一系列合成方法的兼容性而受到重视,使它成为研究和工业应用的实用选择.

结构式图片

相似化合物

32460-02-9 30544-34-4 32460-06-3

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号32460-02-9 3,4-二溴呋喃 | CAS号5458-08-2 trans-5,6-dibro... | CAS号108-86-1 溴苯 | CAS号10420-90-3 1,3-Hexadien-5-yne. | CAS号201230-82-2 carbon monoxide | CAS号71-43-2 苯 | CAS号55552-70-0 3-呋喃硼酸 | CAS号488-93-7 3-糠酸;呋喃-3-甲酸 | CAS号13129-23-2 3-呋喃甲酸甲酯 | CAS号56267-48-2 呋喃-3-叔丁基胺 | CAS号52665-49-3 呋喃-3-磺酰氯 | CAS号144104-53-0 5-呋喃-3-基-1H-吲哚

合成工艺路线路线简述

    Trans-5,6-Dibromo-7-Oxabicyclo{2.2.1}Heptane-2-Exo,3-Cis-Dicarboxylic Acid Anhydride置于氢氧化钾体系中,化学反应生成3-溴呋喃
    参考文献:Process For Preparing 3-Halofuran
    标题:Process For Preparing 3-Halofuran

    专利信息


    专利号:US-4749806-A
    优先权日:1984-12-28
    标题:Process for the synthesis of isocyanates and of isocyanate derivatives
    发明人:TKATCHENKO IGOR; JAOUHARI RABIH; BONNET MICHEL; DAWKINS GORDON; LECOLIER SERGE
    权利人:POUDRES & EXPLOSIFS STE NALE
    摘要:The present invention relates to a process for the synthesis of isocyanates and of isocyanate derivatives. Isocyanates are obtained by reacting an organic halide with a metal cyanate in an organic medium in the presence of a catalyst consisting of a complex of nickel with at least one organic ligand, in which complex the nickel is in the zero oxidation state. A carbamate or a urea, respectively, are obtained by a subsequent reaction with a hydroxy compound or a primary or secondary amine. Isocyanates and their derivatives are used especially either as refined synthesis agents for the production of pesticides and medications, or as monomers or comonomers for the preparation of many macromolecular compounds.

    专利号:US-6172205-B1
    优先权日:1997-12-11
    标题 :Synthetic process toward total synthesis of eleutherobin and its analogues and uses thereof
    发明人:DANISHEFSKY SAMUEL J; CHEN XIAO-TAO; GUTTERIDGE CLARE E; BHATTACHARYA SAMIT K; ZHOU BISHAN
    权利人:TRUSTEES OF COLUMBIA IN THE CI
    摘要:This invention provides a process for the preparation of a Eleutherobin derivative of the formula: n wherein R 1 is a hydrogen, ester, nitrile or C 2 H 4 —R wherein R 4 is a carbohydrate, an alcohol an amine, an amide, an alkyne, or, R 2 is a linear or branched alkyl moiety, R 3 is an ester, an amide, a carbamate, an acetal compound,an ether or a urethane, R 4 is a hydrogen or CH 2 ,position C 2 and C 3 is cis or trans,position C 8 is α or β and a compound is produced having the structures: n Additionally, this experiment provides a method for inhibiting growth of cancerous cells comprising contracting an amount of Eleutherobin derivative effective to inhibit the growth of said cells. Further provided is a method for treating cancer in a subject which comprises administering to the subject a therapeutically effective amount of the Eleutherobin derivative.

    专利号:US-9034439-B2
    优先权日:2008-03-04
    标题:Synthesis and applications of soluble pentacene precursors and related compounds
    发明人:CHOW TAHSIN J; WU CHUNG-CHIH; CHUANG TA-HSIEN; HSIEH HSING-HUNG; HUANG HSIN-HUI
    权利人:CHOW TAHSIN J; WU CHUNG-CHIH; CHUANG TA-HSIEN; HSIEH HSING-HUNG; HUANG HSIN-HUI; ACADEMIA SINICA
    摘要:The present disclosure relates to methods and systems for synthesis of bridged-hydropentacene, hydroanthracene and hydrotetracene from the precursor compounds pentacene derivatives, tetracene derivatives, and anthracene derivatives. The invention further relates to methods and systems for forming thin films for use in electrically conductive assemblies, such as semiconductors or photovoltaic devices.

    专利号:US-11512075-B2
    优先权日:2017-06-14
    标 题:Synthesis of 20-nor-salvinorin A
    发明人:SHENVI RYAN; ROACH JEREMY; SASANO YUSUKE; BOHN LAURA; SCHMID CULLEN
    权利人:SCRIPPS RESEARCH INST
    摘要:The invention provides 20-nor-salvinorin A, an analog of the kappa-opioid agonist salvinorin A. The 20-nor-salvinorin A is an active kappa-opioid modulator and can be used for treatment of medical conditions wherein modulation of the kappa-opioid receptor is medically indicated, such as pain, pruritis, depression, or inflammation, or conditions implicating perception and consciousness. 20-nor-salvinorin A can be less additive when used in treatment compared to a mu-opioid receptor agonist, and 20-nor-salvinorin A is more stable in vivo than is parent compound salvinorin A. The invention further provides synthetic intermediates and procedures for preparation of 20-nor-salvinorin A.

    专利号:US-2008280855-A1
    优先权日:2005-06-22
    标 题 :Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles
    发明人:CHIESA MARIA VITTORIA; PALMER ANDREAS; BUHR WILM; ZIMMERMANN PETER JAN; BREHM CHRISTOF; SIMON WOLFGANG-ALEXANDER; POSTIUS STEFAN; KROMER WOLFGANG; ZANOTTI-GEROSA ANTONIO
    权利人:NYCOMED GMBH
    摘要:The invention relates to a process for the synthesis of compounds of the formula 1-a and compounds of the formula 1-b. n n n n n n n n n n The compounds of the formula 1-a and the compounds of the formula 1-b, in which the substituents R1, R2, R3, and Ar have the meanings indicated in the description, are valuable intermediates for the preparation of pharmaceutically active compounds.

    专利号:US-4259240-A
    优先权日:1979-09-28
    标 题:Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
    发明人:WIESNER KAREL; TSAI THOMAS Y R
    权利人:ADVANCE BIOFACTURES CORP
    摘要:The invention relates to furyl intermediates and the preparation thereof, said intermediates being particularly useful in the preparation of synthetic cardenolides and their isomers. The process provides for the reaction of an unsaturated steroidal 17 ketone with a β-furyl compound to produce an allylic alcohol which is subjected to acetylation and allylic rearrangement. The resulting material is then hydrogenated to produce the furyl intermediate. Cardenolides are formed therefrom by oxidation of the furyl intermediates.
    珠海奥博凯生物医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aobchem.com.cn
    企业联系电话:15697568807👤
    📞珠海奥博凯生物医药技术有限公司 ⚠️参考联系方式
    联系人:赵金杰
    电话:15697568807
    手机:15697568807

    邮箱:zhao.jinjie@aobchem.com.cn
    通信地址: 广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    邮编: 519090
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉朋和科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.boronicgroup.com
    电话: 027-60707801 13628634921👤
    📞武汉朋和科技有限公司 ⚠️参考联系方式

    销售电话:027-60707801 13628634921
    邮箱:sunny.w@boronicgroup.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东湖新技术开发区高新大道999号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州中集化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.czzjchem.com
    电话:0519-85156279-811/812👤
    📞 常州中集化工有限公司⚠️参考联系方式

    电话: 0519-85156279-811/812
    邮件:sales@czzjchem.com
    网址: http://www.czzjchem.com
    地址:常州市新北区世府邻里中心
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    常州市新北区世府邻里中心
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Adam Mccluskey, Et Al. Cantharidin Analogues: Synthesis And Evaluation Of Growth Inhibition In A Panel Of Selected Tumour Cell Lines. Bioorg Chem. 2003 Feb;31(1):68-79.

    合成参考文献


    摘要:Hou, X.-L.; Peng, X.-S.; Yeung, K.-S.; Wong, H. N. C., Science of Synthesis Knowledge Updates, (2011) 2, 349.
    摘要:Ihmels, H., Science of Synthesis Knowledge Updates, (2011) 1, 85.
    摘要:Rudzinski, D. M.; Leadbeater, N. E., Science of Synthesis Knowledge Updates, (2012) 1, 403.
    摘要:Kawęcki, R., Science of Synthesis Knowledge Updates, (2018) 4, 366.
    摘要:Wang, K.; Wang, J., Science of Synthesis, (2022) , 30.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知